[1]
Isabella Alvarez and Daniel Perez, “The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study”, sjim, vol. 2, no. 1, pp. 25-36, Nov. 2023.